Assessment of the efficacy of novel inhibitors against pancreatic cancer

• Unité de recherche: INNOSUISSE
• Numéro de projet: 40922.1 IP-LS
• Titre du projet anglais: Assessment of the efficacy of novel inhibitors against pancreatic cancer

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

Pancreatic cancer (PDAC) is marked by rich desmoplastic stroma and immunosuppression. The proposed project will deliver mechanistic information and efficacy data of two novel inhibitors of PDAC, providing a strong rationale for entering clinical studies in PDAC patients with these therapeutics.